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The  purpose  of  this  systematic  review  is  to  identify,  describe  and  assess  the potential  effectiveness  of
strategies  to respond  to issues  of vaccine  hesitancy  that have  been  implemented  and  evaluated  across
diverse  global  contexts.
Methods: A  systematic  review  of  peer  reviewed  (January  2007–October  2013)  and  grey literature  (up
to  October  2013)  was  conducted  using  a broad  search  strategy,  built  to capture  multiple  dimensions  of
public  trust,  conﬁdence  and hesitancy  concerning  vaccines.  This  search  strategy  was  applied  and  adapted
across  several  databases  and  organizational  websites.  Descriptive  analyses  were  undertaken  for  166 (peer
reviewed)  and  15  (grey  literature)  evaluation  studies.  In addition,  the  quality  of evidence  relating  to  a
series of  PICO  (population,  intervention,  comparison/control,  outcomes)  questions  deﬁned  by  the  SAGE
Working  Group  on  Vaccine  Hesitancy  (WG)  was  assessed  using  Grading  of  Recommendations  Assessment,
Development  and  Evaluation  (GRADE)  criteria;  data  were  analyzed  using  Review  Manager.
Results:  Across  the  literature,  few  strategies  to address  vaccine  hesitancy  were  found  to  have  been  eval-
uated  for impact  on  either  vaccination  uptake  and/or  changes  in  knowledge,  awareness  or  attitude  (only
14%  of  peer  reviewed  and  25%  of  grey  literature).  The  majority  of  evaluation  studies  were based  in  the
Americas  and  primarily  focused  on  inﬂuenza,  human  papillomavirus  (HPV)  and  childhood  vaccines.  In
low-  and  middle-income  regions,  the  focus  was  on diphtheria,  tetanus  and pertussis,  and  polio.  Across
all  regions,  most  interventions  were  multi-component  and  the  majority  of strategies  focused  on  raising
knowledge  and  awareness.  Thirteen  relevant  studies  were used  for the  GRADE  assessment  that  indicated
evidence  of moderate  quality  for the use of  social  mobilization,  mass  media,  communication  tool-based
training  for  health-care  workers,  non-ﬁnancial  incentives  and  reminder/recall-based  interventions.
Overall, our  results  showed  that  multicomponent  and  dialogue-based  interventions  were  most  effec-
tive.  However,  given  the  complexity  of  vaccine  hesitancy  and  the  limited  evidence  available  on  how  it
can  be addressed,  identiﬁed  strategies  should  be  carefully  tailored  according  to the  target  population,
their  reasons  for  hesitancy,  and  the  speciﬁc  context.
©  2015  Published  by  Elsevier  Ltd.  This  is an open  access  article  under  the  CC  BY  license  (http://. IntroductionThe dynamic and challenging period of indecision around
ccepting a vaccination – often referred to as “vaccine hesitancy”5
 Some of the authors are World Health Organization staff members. The opinions
xpressed in this article are those of the authors and do not necessarily represent
he decisions, ofﬁcial policy or opinions of the World Health Organization.
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E-mail address: Heidi.Larson@lshtm.ac.uk (H.J. Larson).
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4 Members of SAGE Working Group on Vaccine Hesitancy are listed in Appendix.
5 Vaccine hesitancy “refers to delay in acceptance or refusal of vaccines despite
vailability of vaccination services. Vaccine hesitancy is complex and context spe-
ttp://dx.doi.org/10.1016/j.vaccine.2015.04.040
264-410X/© 2015 Published by Elsevier Ltd. This is an open access article under the CC creativecommons.org/licenses/by/3.0/).
– is being increasingly studied. Given the growing concern in many
countries about vaccine hesitancy, the Strategic Advisory Group of
Experts (SAGE) Working Group (WG) on Vaccine Hesitancy6 asked
that a review focused on strategies to address hesitancy be under-
taken.
The purpose of this systematic review was to identify strate-
gies that have been implemented and evaluated across diverse
global contexts in an effort to respond to, and manage, issues
of vaccine hesitancy. This review was conducted to inform the
ciﬁc varying across time, place and vaccines. It includes factors such as complacency,
convenience and conﬁdence” (WHO SAGE meeting, October 2014).
6 http://www.who.int/immunization/sage/sage wg vaccine hesitancy apr12/
en/ [accessed 02.02.15].
BY license (http://creativecommons.org/licenses/by/3.0/).
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ecommendations of the SAGE WG,  building on the previous review
f determinants of vaccine hesitancy [1].
. Methods
.1. Search strategy
For the peer-reviewed literature, the following databases were
earched for the period of January 2007–October 2013: Medline,
mbase, PsychInfo, Cochrane, CINAHL Plus, Web  of Science, LILACS,
frica-Wide Information (for these, the search range was  2007 to
 October 2013); IBSS (2007 to 19th July 2013) and IMEMR  (2007 to
0 October 2013). The applied search strategy was  kept deliberately
road to try to capture the multiple facets of vaccine hesitancy and
ncorporated MeSH or equivalent terms [Appendix 1]. References
n relevant papers were searched for further relevant studies.
For grey literature, an open-dated search ending, in October
013, was conducted across several databases and organiza-
ional websites, which included: OpenGrey, New York Academy
f Medicine, Global Health, National Institute for Health and
are Excellence (NICE), Department for International Development
DFID), the Communication Initiative Network and the Polio Com-
unication Initiative Network [see search terms in Appendix 2].
irect email requests were sent to individuals/organizations iden-
iﬁed by the SAGE WG.
.2. Study selection – Part A (Identiﬁcation, scope of literature
nd effect of evaluated interventions)
For peer-reviewed literature, studies were included against the
ollowing criteria: (i) contained research on vaccine hesitancy; (ii)
ncluded any of the keywords in the title or abstract: “strateg*”,
intervent*”, “campaign”, “evaluation”, “approach” or “program*”;
iii) described or evaluated an intervention addressing hesitancy
nd reported a measure of the primary outcome, i.e. indicating a
hange in vaccination uptake or the secondary outcome, i.e. indi-
ating a change in knowledge/awareness and/or attitudes; (iv)
ublished between January 2007 and October 2013; (v) pertaining
o any vaccines and vaccination programmes; (vi) published in any
f the six ofﬁcial UN languages (Arabic, Chinese, English, French,
ussian and Spanish).
Grey literature was selected based on the following inclusion
riteria: (i) contained any of the keywords
“immunisation/immunization”, “vaccine”, “vaccination”, “strat-
egy”, “intervention”, “evaluation”, “hesitancy”, “refusal”, “trust”,
“conﬁdence”, “acceptance”, “engagement”, “anxiety”, “con-
cern”, “distrust”, “barrier”, “rejection”, “fear”; (ii) published
anytime up to October 2013; (iii) English only. Literature was
excluded if it was: (i) about non-human vaccines or vaccines
not currently available (e.g. HIV); (ii) related to research and
development of vaccines (e.g. efﬁcacy trials) unless explicitly
about public trust, conﬁdence, concern or hesitancy.
The screening of titles and abstracts was shared between at
east two authors; a sample of studies was independently coded
y authors to ensure consistency.
.3. Data extraction
.3.1. Part A
A data extraction form was developed by the authors and
eviewed by the SAGE WG.  For evaluation studies, information
xtracted included details about the speciﬁc hesitancy issue; type
f intervention (dialogue-based, incentive-based, reminder–recall (2015) 4180–4190 4181
based or multi-component), the type of participants, setting and
target vaccine; and the ﬁndings related to the outcomes of interest.
2.3.2. Part B (PICO & GRADE) – Study selection, risk of bias &
analysis
The SAGE WG identiﬁed 15 PICO (Population, Intervention,
Comparator, Outcome) questions [2] [Appendix 3] a priori, to exam-
ine population features likely to inﬂuence the effect of different
interventions and to assess the quality of evidence for each PICO
question using GRADE (Grading of Recommendations, Assessment,
Development, and Evaluation) [3]. The primary outcome of inter-
est was  deﬁned as the uptake of all vaccines included in routinely
recommended immunization.
The 15 PICO questions were developed under three intervention
themes: (1) Dialogue-based, (2) incentive-based (non-ﬁnancial),
and (3) reminder–recall. Following an extensive discussion by the
WG at the December 2013 meeting, it was decided to focus on
the impact of single component approaches and exclude multi-
component approaches. However, data were included where a
multi-component intervention provided suitable data to assess the
effect of its individual component parts.
Theme categories for PICO questions:
i) Dialogue-based, including the involvement of religious or tra-
ditional leaders, social mobilization, social media, mass media,
and communication or information-based tools for health-care
workers (HCW);
ii) Incentive-based (non-ﬁnancial), including the provision of
food or other goods to encourage vaccination, and;
iii) Reminder/recall-based, including telephone call/letter to
remind the target population about vaccination.
Evaluated primary studies identiﬁed earlier (Part A) were
included if they provided direct evidence relevant to one or more
PICO questions and reported data for comparison groups. Reasons
for excluding studies are presented in Characteristics of excluded
studies [4].
2.3.3. Assessment of risk of bias
The Effective Public Health Practice Project (EPHPP) qual-
ity assessment tool for quantitative studies [5] was applied to
determine the risk of bias of all eligible studies. Two reviewers
independently conducted the risk of bias assessment and data
extraction; disagreements were settled through discussion.
2.3.4. Data analysis
For studies which included pre- and post-control and interven-
tion groups, only post-data were used to more accurately represent
the effect of the intervention. Outcomes reported varied between
studies, so available data were entered into Review Manager soft-
ware as individual studies. The ﬁxed-effects model was used for
analysis and results reported as risk ratios between intervention
and control groups.
3. Results
3.1. Part A – Identiﬁcation, scope of literature and effect of
evaluated interventions
The search of peer reviewed publications identiﬁed 33023 peer
reviewed articles. After removing duplicates and screening for
inclusion criteria, 1149 articles were included by full-text. Of these,
166 [6–172] evaluated and 983 described, but did not evaluate, an
intervention. Among the evaluated studies included from the peer
reviewed literature, 115 related to Outcome 1, 37 to Outcome 2,
and 14 to both [Fig. 1].
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evaluated studies anticipating or researching acceptance of the
newly introduced HPV vaccine.
7 The World Health Organization (WHO) divides the world into six WHO  regions,
for  the purposes of reporting, analysis and administration: WHO  African RegionFig. 1. Search process ﬂow chart (pee
The grey literature search identiﬁed 4896 records. After remov-
ng duplicates and screening for inclusion criteria, 59 articles were
ncluded by full text. Of these, 15 evaluated [172–186] and 44 only
uggested an intervention. Among the evaluated studies included
rom the grey literature, nine reported on Outcome 1, three on
utcome 2, and three on both [Fig. 2].
There were a total of 181 articles that evaluated interventions
rom the peer reviewed and grey literature search, combined.
The number of peer reviewed studies evaluating interventions
eaked in 2011 (at 32 studies) and has remained relatively stable
ince (28 in 2012 and 25 in 2013) [Fig. 3].
Very few evaluated interventions were identiﬁed in the grey lit-
rature with one or two articles annually at most from 1996 to 2012.
n 2013, eight relevant articles (47% of those identiﬁed through the
rey literature search) were found [Fig. 4].
Across all the literature reviewed (1208 articles), only ﬁve (0.4%)
sed the actual term ‘hesitancy’ or ‘hesitant’ with reference to
accines/vaccination [94,173–176]. These were all found in the
eer-reviewed literature and were all published in 2013. Only one
f these articles evaluated an intervention. This intervention was
arried out in AMR  and focused on childhood vaccines, targetingewed literature) – Vaccine hesitancy.
vaccine hesitant parents using a multi-component strategy that
focused on education techniques. More often articles used terms
such as “refusal”, “distrust” and “acceptance” to discuss vaccination
behaviour. This reﬂects the relative newness of the term “hesi-
tancy”.
The majority (58%) of evaluation studies in the peer reviewed
and grey literature were based in AMR7 (110/1898), and primar-
ily focused on inﬂuenza, HPV and childhood vaccines. In low- and
middle-income regions, particularly SEAR and AFR, the focus was
on Diphtheria, Tetanus, Pertussis (DTP) and polio. All regions had(AFR), WHO  Region of the Americas (AMR), WHO  South-East Asia Region (SEAR),
WHO  European Region (EUR), WHO  Eastern Mediterranean Region (EMR) and WHO
Western Paciﬁc Region (WPR).
8 The total number of articles is more than (n = 166) (peer reviewed) and (n = 15)
(grey literature) as some articles report on more than one WHO  region.
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Most interventions (primarily in AMR  and EUR) targeted par-
nts, health-care workers (HCWs) and the local community.
nterventions in the grey literature from AFR largely focused on
he local community and religious leaders.
When mapped against the SAGE WG model of determinants
f vaccine hesitancy [Appendix 4], interventions addressing indi-
idual and social group inﬂuences, particularly knowledge and
wareness raising, were most common in both the peer reviewed
nd grey literature (157/341, 46%). Vaccine delivery and the role
ig. 3. Evaluated peer reviewed strategies by publication year (2007–2013) and WHO  r
eport  on more than one WHO  region. literature) – Vaccine hesitancy.
of the HCWs were the primary focus of vaccine and vaccination-
speciﬁc interventions (123/3416, 36%). The engagement of religious
and other community leaders was most commonly used to address
contextual inﬂuences such as religion, culture and gender [Fig. 5].
In both the peer reviewed and grey literature, across all
regions, most interventions (97/127, 76%) were multi-component.
Dialogue-based interventions were common in all regions except
EMR; reminder–recall approaches featured predominantly in
higher-income regions; and incentive-based interventions were
egion (n = 172)*. *Total number of articles is more than (n = 166) as some articles
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nly found in AMR  and AFR (single-component), and SEAR (part
f a multi-component approach).
.2. Which interventions have been most successful?
The most effective interventions employed multiple strategies.
he interventions with the largest observed increases (>25%) in
accine uptake (Outcome 1) were those that (not in order of impor-
ance): (1) directly targeted unvaccinated or under-vaccinated
opulations [13]; (2) aimed to increase vaccination knowledge
nd awareness [20]; (3) improved convenience and access to
ig. 5. Evaluated peer reviewed and grey literature strategies by the SAGE WG model of d
ne  determinant of vaccine hesitancy.ion (n = 17)*. *Total number of articles is more than (n = 16) as some articles report
vaccination [116]; (4) targeted speciﬁc populations (e.g. HCW)
[9]; (5) mandated vaccinations or sanction against non-vaccination
[46]; and (6) engaged religious or other inﬂuential leaders to
promote vaccination [177]. The greatest increases (>20%) in knowl-
edge, awareness or attitudes (Outcome 2) were observed with
education initiatives, particularly those embedding new knowl-
edge into routine processes (e.g. hospital procedures), which were
most successful at increasing knowledge and changing attitudes
[105]. For both outcomes, those that tailored interventions to spe-
ciﬁc populations and their speciﬁc concerns were most effective
[23,38].
eterminants of vaccine hesitancy (n = 344). *Interventions could address more than
ine 33
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.3. Which interventions have been least successful?
Interventions associated with a less than 10% increase in uptake
ncluded those that focused on quality improvement at clinics (e.g.
mproved data collection and monitoring, extended clinic hours
8,58], passive interventions (e.g. posters, websites [19,24,41] and
ncentive-based interventions using conditional or non-conditional
ash transfers. It must be noted that incentive-based interventions
sually targeted general preventive health and not just vaccination
96,98]. Lastly, reminder–recall interventions were associated with
ariable changes in uptake [57,75,88].
.4. Part B – PICO & GRADE
Of 129 studies available, only 13 studies met  the inclusion crite-
ia for GRADE evaluation. The methodological quality (risk of bias)
f each is set out in Appendix 5. Further study details are presented
n Appendix 6.
The delivery of interventions varied as did the outcomes. Con-
equently only one outcome (two studies) for a single vaccine
as pooled; meta-analysis was not feasible for any other outcome
64,66]. Summary of relative risk ratios (RR) and evidence quality
GRADE) for each question are presented in Appendix 3. Of the 15
ICO questions, only 10 could be addressed, often with only 1 study
ith evidence.
. Dialogue-based interventions
Eleven studies evaluated by PICO and GRADE deployed
ialogue-based interventions (explained below). There was appre-
iable variability in the quality of evidence supporting the use of
hese interventions and their impact varied considerably, by type
f intervention, by vaccine and by setting.
For polio, the involvement of religious or traditional leaders
n populations with low baseline uptake indicated a large, posi-
ive effect (RR 4.12 [3.99, 4.26]) on vaccine uptake but the evidence
uality was assessed as very low [65] (Nigeria). The grey literature
lso reinforced that religious and traditional leader involvement
an have a positive impact [3,5,177,178] as in west and central
rancophone African countries, Afghanistan, India and Europe.
Four studies using social mobilization among parents in low-
ncome settings found a positive effect on measles (RR 1.63 [1.39,
.91]) [78] (Pakistan), DTP3 (RR 2.17 [1.8, 2.61]) [78] (Pakistan),
TP1 (RR 1.54 [1.1, 2.15]) [106] (Nigeria), and polio (RR 1050.00
147.96, 7451.4]) [66] (Pakistan) [64] (India) vaccine uptake. The
uality of evidence for each outcome ranged from moderate
measles, DTP3), to low (polio) and very low (DTP1). Two  stud-
es targeting polio vaccination refusals reported large increases in
ptake. In the grey literature, inclusion of social mobilization as a
omponent appeared to have a positive, albeit varied effect and was
ot always quantiﬁed.
Two studies evaluating social media interventions found a
ositive effect on uptake for MCV4/Tdap (RR 2.01 [1.39, 2.93])
102] (Australia) and seasonal inﬂuenza (RR 2.38 [1.23, 4.6]) [157]
Australia) although the evidence was assessed as low and very low
uality. In the grey literature, one study [178] in Slovenia reported
n the use of social media with other strategies for A(H1N1), how-
ver its effect was not independently measured, achieved low
tilization, and became a source of negative social media rumours.
A study on mass media to target parents with low awareness
f health services found an association with increased uptake of all
outinely recommended vaccines (RR 1.57 [1.4, 1.75]) [179] (India).
he quality of evidence was moderate. Three grey literature studies
eported on the use of mass media for A(H1N1) [178] (Europe), rou-
ine childhood immunization [177] (west and central francophone (2015) 4180–4190 4185
African countries) and polio [3] (Afghanistan) but their impact was
not independently measured from other intervention components.
Communication tool-based training for health-care work-
ers had a positive impact on uptake of EPI vaccines (RR 3.09
[2.19, 4.36]) [92] and DTP3 (RR 1.54 [1.33, 1.79]) [79] in India and
Pakistan respectively, among rostered patients; evidence quality
was assessed as moderate and low respectively.
One study [10] (Turkey) assessed the impact of information-
based training for health-care workers on uptake for rostered
patients, with varying results. There was little or no increase in
uptake of DTP/OPV-1 (RR 0.99 [0.93, 1.06]), DTP/OPV-2 (RR 1.04
[0.97, 1.12]), BCG (RR 1.01 [0.95, 1.08]) and measles (RR 1.02 [0.96,
1.09]), a moderate increase in uptake of HepB-2 (RR 1.63 [1.49,
1.79]), HepB-3 (RR 1.89 [1.74, 2.04]) and DTP/OPV-3 (RR 1.42 [1.33,
1.51]), and a substantial increase in uptake of HepB-1 (RR 2.83 [2.6,
3.08]); but the evidence quality was  very low for all.
5. Non-ﬁnancial incentives
The evidence for non-ﬁnancial incentives for par-
ents/communities located in low-income settings (India) was
moderate for a large, positive effect on EPI vaccine uptake (RR 2.16
[1.68, 2.77]) [92].
6. Reminder–recall interventions
Two  studies assessed the impact of reminder–recall interven-
tions in low-income and under-vaccinated populations. The impact
of reminder–recall interventions in low-income settings was  posi-
tive for DTP3 (RR 1.26 [1.13, 1.42]) [146] (Pakistan) with moderate
quality evidence. For settings with low baseline uptake, the effects
were large and positive for scheduled childhood vaccines (RR 3.22
[1.59, 6.53]) [86] (Switzerland) but the quality of evidence was  very
low.
7. Discussion
7.1. Part A – Identiﬁcation, scope of literature and effect of
evaluated interventions
While there has been an increase in the number of articles
on the issue of vaccine hesitancy, of those that include a discus-
sion on interventions or strategies to address hesitancy, few go
as far as evaluating them. Furthermore, the speciﬁc term “vac-
cine hesitancy” has only recently been used and the only evaluated
intervention that explicitly addressed “hesitancy” comes from the
United States.
Overall, many of the interventions were not different from tradi-
tional strategies to increase vaccine acceptance, with the majority
focusing at individual and social group level and interventions
being largely on knowledge and awareness raising. While knowl-
edge and awareness raising strategies are important, they are
inadequate, as evidenced by the ﬁnding that the most effective
interventions used multi-component strategies. Furthermore the
most effective interventions were tailored to speciﬁc populations
and addressing speciﬁc concerns, pointing to the importance of
understanding the drivers of vaccine hesitancy to inform the inter-
ventions.
The increasingly recognized domain of vaccine hesitancy needs
new interventions to address new issues. In particular, the dearth of
interventions identiﬁed in low-income countries needs attention.7.2. Part B – PICO & GRADE
Despite the few studies available for GRADE and variability in
the quality of the evidence, several interventions showed some
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ositive impact on vaccination uptake, including: social mobiliza-
ion, mass media, communication tool-based training for HCW,
on-ﬁnancial incentives, and reminder–recall activities. None of
hese interventions were without shortcomings, and given the vari-
bility in context, target population and outcome, the potential
pplication of these interventions must be cautiously considered
hen applying them in different circumstances.
. Dialogue-based interventions
The impact of religious or traditional leader involvement
n populations with low baseline uptake merits further inves-
igation and evaluation. This type of intervention is important
s it addresses one of the more difﬁcult determinants of vac-
ine hesitancy, namely, misconceptions and community distrust.
his intervention aligns itself with natural community processes –
eeking out community leaders, and encouraging dialogue across
ultiple levels to both inform and inﬂuence. The success of the
ntervention could be attributed to the efforts made to understand
he target audience, facilitate open dialogue, and integrate activities
ith familiar processes and systems.
The success of social mobilization interventions for popula-
ions refusing polio vaccination could also be attributed to the tar-
eting of, and dialogue with, a clearly deﬁned population. By com-
arison, the social mobilization interventions for measles and DTP
ere much less targeted; although positive outcomes appear to be
ue to meaningful dialogue at both the group and individual level.
Social media intervention studies suggest that this approach
ight work well for those who have already started their vacci-
ation schedule, or who are familiar with social media in other
spects of their lives. However, there is important evidence that
ocial media are also very open to exploitation if not managed well.
lso those who initiate vaccination are probably not the most hes-
tant of populations and those with access to social media are not
he most marginalized.
The use of mass media to target populations with low aware-
ess of health services appears to be effective, however, the limited
mpact also suggests that there may  be other underlying issues
ffecting the impact that need investigation and more tailored sup-
orting interventions.
The provision of communication tool-based training for HCW
enerally had a positive effect (for EPI vaccines, DTP3) but the size
f the effect and evidence quality varied. The observations about
his example and mass media suggest that interventions that adopt
 unidirectional (top down) approach to communication, may  be
uccessful among some individuals and groups, but not all; success
s dependent on the nature and degree of hesitancy.
The impact of information-based training for HCW on uptake
f several vaccines for rostered patients was generally poor. A
ossible explanation for these results is that there was no clear
nderstanding of the underlying reasons for the low vaccination
ptake and as such, the intervention was not appropriately tar-
eted. Nonetheless, the intervention did achieve good success with
epB (all doses) and DTP/OPV (dose 3); one possible reason for
his is that the HCW exhibited greater conﬁdence but it is not clear
hether this was an issue prior to the intervention.
. Non-ﬁnancial incentives
The moderate to large effect of non-ﬁnancial incentives for par-
nts/communities located in low-income settings on vaccination
ptake is promising. In this study the target group was very dis-
dvantaged and the food-based incentive, so closely linked with
asic survival, was readily received. Furthermore, the baseline
accination rates were very low (2%), and more likely to show (2015) 4180–4190
greater outcome changes with an intervention. It is possible that
by addressing basic needs, this intervention simultaneously built
conﬁdence and reduced vaccine hesitancy because the target pop-
ulation felt that their other critical needs were being addressed. This
approach could be particularly important for underserved groups.
10. Reminder–recall interventions
Although positive, the relatively low observed effect of
reminder–recall interventions in low-income settings seems to
reﬂect the limitations of using this kind of intervention alone. In
this example, a complex set of issues was identiﬁed in the tar-
get population but the intervention only addressed one of them.
Reminder–recall on its own is not enough to tackle multiple causes
of hesitancy.
11. Limitations
This review may  be subject to publication bias, in that unsuc-
cessful interventions may  be less likely to be documented in either
the peer-reviewed or grey literature. Another reason for the paucity
of relevant studies is that the PICO questions emphasize spe-
ciﬁc, single component strategies, but many evaluated strategies
are neither designed nor presented in this way. Evaluated, multi-
component interventions were identiﬁed but only overall impact
data were presented. Therefore, outcome data for individual strate-
gies to address vaccine hesitancy were not separately available.
12. Conclusion
Overall this review has found that, despite extensive litera-
ture searching, there are (1) few existing strategies that have been
explicitly designed to address vaccine hesitancy; and (2) even fewer
strategies that have quantiﬁed the impact of the intervention (14%
(166/1149) of peer reviewed; 25% (15/59) of the grey literature).
There is also an uneven geographical spread in the available litera-
ture, with most focusing on AMR  and EUR.
Efforts to address issues of hesitancy are disparate. While a
number of interventions did have a positive effect, wide variation
was observed in the effect size between studies, settings and tar-
get populations. In addition, the high level of heterogeneity across
study design and outcomes, coupled with few available studies,
further limited our ability to draw many general conclusions about
the effectiveness of different strategies.
Nonetheless, interventions to increase uptake that are multi-
component and/or have a focus on dialogue-based approaches tend
to perform better. Together, these interventions suggest that taking
a comprehensive approach that targets multiple audiences and lay-
ers of social interaction are more likely to bring positive results. The
evidence for non-ﬁnancial incentives and reminder–recall activ-
ities was  also of good quality, and carries the potential to bring
positive change by addressing the more practical aspects of vacci-
nation.
Vaccine hesitancy is a complex issue and no single strategy will
be able to address it. There are some promising examples using
uptake as a link, but many are incomplete and most are not directly
comparable. One of the greatest drawbacks of the interventions
identiﬁed is that many operate from an assumption-based rather
than an evidence-based approach; appropriate evaluation is also
lacking. On a more positive note, there is a growing body of research
on the determinants of vaccine hesitancy which can help inform
and reﬁne currently used approaches that look promising but have
not yet been fully implemented or evaluated.
Lastly, there is a clear need for more attention to under-
standing and addressing hesitancy at the community and social
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etwork level – most interventions have historically focused on
ddressing individual level issues (e.g. knowledge, awareness) and
accine/vaccination speciﬁc concerns (e.g. mode of delivery, vac-
ine risks) despite the large body of literature on the many other
eterminants of vaccine hesitancy.
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